In Analysis | October 2024

Birth Surveillance in Eswatini Following Transition To Dolutegravir-based Treatment

Overview

Country:

Eswatini

Subject Matter:

Maternal, Newborn, and Child Health; PMTCT and HIV-free Survival

The aim of this ViiV-funded observational study is to evaluate the birth outcomes of HIV-positive women who are receiving Dolutegravir or other ARV drug regimens in Eswatini.

Data Collection Period: 08/2021 – 09/2023

Publications and Presentations:

  1. Findings published in Open Forum Infectious Diseases, August 2023: Strengthening the Evidence: Similar Rates of Neural Tube Defects Among Deliveries Regardless of Maternal HIV Status and Dolutegravir Exposure in Hospital Birth Surveillance in Eswatini

Explore Other Research

Ongoing Data Collection Pediatric HIV community case finding and assessment of PMTCT effectiveness in Lesotho PMTCT and HIV-free Survival
Completed Knowledge, Attitudes and Practices Related to Oral Pre-exposure Prophylaxis (PrEP) for HIV among Pregnant and Lactating Women in Eswatini Adult Testing, Care, and Treatment; Maternal, Newborn, and Child Health
Ongoing Data Collection Assessment of Birth Outcomes in Eswatini after Transition to Dolutegravir-based Treatment Maternal, Newborn, and Child Health; Pediatric and Adolescent Testing, Care, and Treatment
All Research